Trade Summary

1 week ago, Waheed Nadia, serving as Chief Medical Officer at Ocular Therapeutix, Inc (OCUL), sold 3,510 shares at $7.74 per share, for a total transaction value of $27,167.00. Following this transaction, Waheed Nadia now holds 314,907 shares of OCUL.

This sale represents a 1.00% decrease in Waheed Nadia's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Friday, February 20, 2026 and publicly disclosed via SEC Form 4 filing on Tuesday, February 24, 2026, 4 days after the trade was made.

Ocular Therapeutix, Inc operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.